WINDTREE THERAPEUTICS INC Intellectual Property Contracts & Agreements

8 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License, Development and Commercialization Agreement, by and between the Company and Lees Pharmaceutical (HK) Ltd., dated January 12, 2024
License Agreements
WINDTREE THERAPEUTICS INC
2024
Amendment No. 1, effective as of January 17, 2024, to the License Agreement, between Windtree and Philip Morris Products S.A. dated March 28, 2008
License Agreements
WINDTREE THERAPEUTICS INC
2024
Amendment No. 1, effective as of January 17, 2024, to the Amended and Restated License Agreement, between Windtree and Philip Morris USA Inc. dated March 28, 2008
License Agreements
WINDTREE THERAPEUTICS INC
2024
Amended and Restated License, Development and Commercialization Agreement, by and among Lees Pharmaceutical (HK) Ltd., Zhaoke Pharmaceutical (Hefei) Co. Ltd., and Windtree...
License Agreements
WINDTREE THERAPEUTICS INC
Biotechnology
DE
2022
Amendment No. 1 dated as of August 14, 2017 to the License Development and Commercialization Agreement by and between the Company and Lees Pharmaceutical (HK) Ltd. dated as of...
License Agreements
WINDTREE THERAPEUTICS INC
Biotechnology
2017
LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between windtree therapeutics, inc. and Lee’s pharmaceutical (hk) LTD. Table of Contents
License Agreements
WINDTREE THERAPEUTICS INC
Biotechnology
2017
Exhibit 10.5 Confidential Treatment Requested Execution Version LICENSE AGREEMENT by and between DISCOVERY LABORATORIES, INC. (a Delaware corporation) and PHILIP MORRIS PRODUCTS...
License Agreements
WINDTREE THERAPEUTICS INC
Biotechnology
2008
AMENDED AND RESTATED LICENSE AGREEMENT by and between DISCOVERY LABORATORIES, INC. (a Delaware corporation) and PHILIP MORRIS USA INC., d/b/a CHRYSALIS TECHNOLOGIES (a Virginia...
License Agreements
WINDTREE THERAPEUTICS INC
2008